Drug Pipeline News

>

Latest News

FDA approves clonidine hydrochloride to treat ADHD in patients 6 years and up | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves clonidine hydrochloride to treat ADHD in patients 6 years and up

May 29th 2024

The once daily extended-release oral suspension with nighttime dosing is approved to treat ADHD as a monotherapy or as an adjunctive therapy to approved CNS stimulant medications.

FDA expands label for lipid injectable emulsion to preterm and term neonates | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA expands label for lipid injectable emulsion to preterm and term neonates

May 15th 2024

FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years

May 13th 2024

FDA approves ALTUVIIIO updated label for bleed protection in children with hemophilia | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves ALTUVIIIO updated label for bleed protection in children with hemophilia

May 13th 2024

DB-OTO improved hearing to normal in child with profound genetic deafness | Image Credit: © Marija - © Marija - stock.adobe.com.
DB-OTO improved hearing to normal in child with profound genetic deafness

May 8th 2024

Latest CME Events & Activities

Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing

View More

Shaping the Management of COPD with Biologic Therapy

View More

Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD

View More

A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology

View More

Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age

View More

Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy

View More

More News

© 2024 MJH Life Sciences

All rights reserved.